In May 2013, the Centers for Medicare and Medicaid Services (CMS) proposed new payment rates for the new MoPath codes. Many laboratories are concerned that these rates undervalue key test areas, including molecular cytogenomic, inherited disease, and cancer testing.
July 8 is the final deadline to respond to these rates and propose new values.
In this webinar, you will learn:
â About the latest developments in MoPath rate setting
â How to participate in the rate setting process to ensure appropriate reimbursement for future molecular diagnostic tests
â How and when to respond to the current rate proposal